diltiazem hydrochloride for injection How Supplied/Storage and Handling

HOW SUPPLIED

Diltiazem Hydrochloride Injection is supplied in single-dose Fliptop vials as follows:

Unit of SaleConcentrationEach
NDC 0409-1171-01
Carton containing 10 Single-Dose Fliptop Vials
25 mg/5 mL
(5 mg/mL)
NDC 0409-1171-11
5 mL Single-Dose Fliptop Vial
NDC 0409-1171-02
Carton containing 10 Single-Dose Fliptop Vials
50 mg/10 mL
(5 mg/mL)
NDC 0409-1171-12
10 mL Single-Dose Fliptop Vial

DILTIAZEM HYDROCHLORIDE INJECTION IS TO BE STORED UNDER REFRIGERATION 2 TO 8°C (36 TO 46°F). DO NOT FREEZE. MAY BE STORED AT ROOM TEMPERATURE FOR UP TO 1 MONTH. DESTROY AFTER 1 MONTH AT ROOM TEMPERATURE. SINGLE-DOSE VIALS. DISCARD UNUSED PORTION.

Diltiazem Hydrochloride for Injection for continuous infusion is supplied in single-dose ADD-Vantage vials as follows:

Unit of SaleSizeEach
NDC 0409-4350-03
Tray containing 10 ADD-Vantage Vials
100 mgNDC 0409-4350-13
100 mg/ADD-Vantage Vial

DILTIAZEM HYDROCHLORIDE FOR INJECTION IS TO BE STORED AT 20° TO 25°C (68° TO 77°F). [SEE USP CONTROLLED ROOM TEMPERATURE.] DO NOT FREEZE. RECONSTITUTED MATERIAL IS STABLE FOR 24 HOURS AT CONTROLLED ROOM TEMPERATURE OR REFRIGERATED 2° to 8°C (36° to 46°F). SINGLE-DOSE VIAL.

Find diltiazem hydrochloride for injection medical information:

Find diltiazem hydrochloride for injection medical information:

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

diltiazem hydrochloride for injection Quick Finder

Prescribing Information
Download Prescribing Information

Health Professional Information

How Supplied/Storage and Handling

HOW SUPPLIED

Diltiazem Hydrochloride Injection is supplied in single-dose Fliptop vials as follows:

Unit of SaleConcentrationEach
NDC 0409-1171-01
Carton containing 10 Single-Dose Fliptop Vials
25 mg/5 mL
(5 mg/mL)
NDC 0409-1171-11
5 mL Single-Dose Fliptop Vial
NDC 0409-1171-02
Carton containing 10 Single-Dose Fliptop Vials
50 mg/10 mL
(5 mg/mL)
NDC 0409-1171-12
10 mL Single-Dose Fliptop Vial

DILTIAZEM HYDROCHLORIDE INJECTION IS TO BE STORED UNDER REFRIGERATION 2 TO 8°C (36 TO 46°F). DO NOT FREEZE. MAY BE STORED AT ROOM TEMPERATURE FOR UP TO 1 MONTH. DESTROY AFTER 1 MONTH AT ROOM TEMPERATURE. SINGLE-DOSE VIALS. DISCARD UNUSED PORTION.

Diltiazem Hydrochloride for Injection for continuous infusion is supplied in single-dose ADD-Vantage vials as follows:

Unit of SaleSizeEach
NDC 0409-4350-03
Tray containing 10 ADD-Vantage Vials
100 mgNDC 0409-4350-13
100 mg/ADD-Vantage Vial

DILTIAZEM HYDROCHLORIDE FOR INJECTION IS TO BE STORED AT 20° TO 25°C (68° TO 77°F). [SEE USP CONTROLLED ROOM TEMPERATURE.] DO NOT FREEZE. RECONSTITUTED MATERIAL IS STABLE FOR 24 HOURS AT CONTROLLED ROOM TEMPERATURE OR REFRIGERATED 2° to 8°C (36° to 46°F). SINGLE-DOSE VIAL.

Medication Guide

Health Professional Information

{{section_name_patient}}

{{section_body_html_patient}}

Resources

Didn’t find what you were looking for? Contact us.

MI Digital Assistant

Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.

Call 800-438-1985*

*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5PM ET Monday to Friday; excluding holidays.

Medical Inquiry

Submit a medical question for Pfizer prescription products.

Report Adverse Event

Pfizer Safety

To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:

Pfizer Safety Reporting Site

*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.

If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.

FDA Medwatch

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.